Abstract

Peanuts are Leguminosae, commonly known as the legume or pea family, and peanut allergy is among the most common food allergies and the most common cause of fatal food reactions and anaphylaxis.The prevalence of peanut allergy increased 3.5-fold over the past two decades reaching 1.4–2% in Europe and the United States. The reasons for this increase in prevalence are likely multifaceted. Sensitization via the skin appears to be associated with the development of peanut allergy and atopic eczema in infancy is associated with a high risk of developing peanut allergy.Until recently, the only possible management strategy for peanut allergy was strict allergen avoidance and emergency treatment including adrenaline auto-injector in cases of accidental exposure and reaction.This paper discusses the various factors that impact the risks of peanut allergy and the burden of self-management on peanut-allergic children and their caregivers.

Highlights

  • Peanuts belong to the botanical family Leguminosae, commonly known as the legume or pea family [1]

  • The only possible management strategy for peanut allergy was limited to the combination of strict allergen avoidance along with an action plan, including having an adrenaline auto-injector (AAI) on hand in case of accidental exposure and reaction to peanut, which is sometimes referred to as an “avoidance management strategy.”. This white paper discusses various factors related to the impact of the risks of peanut allergy and the burden of self-management on peanut-allergic children and their caregivers

  • The AGATE training program is recommended, as it explains in detail both the management of allergic reactions and allergen avoidance strategies [54, 56]

Read more

Summary

Introduction

Peanuts belong to the botanical family Leguminosae, commonly known as the legume or pea family [1]. For example, those to egg and milk, are often limited to infancy and are usually “outgrown” in childhood This is only the case in less than 20% of children with peanut allergy [4,5,6,7]. The only possible management strategy for peanut allergy was limited to the combination of strict allergen avoidance along with an action plan, including having an adrenaline auto-injector (AAI) on hand in case of accidental exposure and reaction to peanut, which is sometimes referred to as an “avoidance management strategy.” This white paper discusses various factors related to the impact of the risks of peanut allergy and the burden of self-management on peanut-allergic children and their caregivers. In a recent prospective study of cross-allergy in peanut and nut allergic patients by Brough et al, approximately 30% of patients reacted to cashew, 28% to walnut and pistachio, 22% to hazelnut, and 20% to pecan [22]

Clinical symptoms and diagnostics
Burden of disease and impact on quality of life
Socioeconomic impact
Management and therapeutic options
European precautionary allergen labeling
Allergen labeling regulations on packaged goods
Allergen labeling of loose goods
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call